An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on: March 07,2024

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on:March 07,2024

Control of the iRhom2 protein may hold the key to preventing Alzheimer's disease

by CORDISCredit: IRHOM2 in ADIt is known that the onset of Alzheimer's disease (AD) is associated with the accumulation of Amyloid beta (Aβ) peptides in small molecular clusters known as olig

Updated on: March 09,2024

Control of the iRhom2 protein may hold the key to preventing Alzheimer's disease

by CORDISCredit: IRHOM2 in ADIt is known that the onset of Alzheimer's disease (AD) is associated with the accumulation of Amyloid beta (Aβ) peptides in small molecular clusters known as olig

Updated on:March 09,2024

Aboriginal Australians in cities have dementia rates as high as those in rural areas

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainStudies have shown that Aboriginal Australians living in remote areas of the country are disproportionately affected by dementia,

Updated on: July 04,2024

Aboriginal Australians in cities have dementia rates as high as those in rural areas

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainStudies have shown that Aboriginal Australians living in remote areas of the country are disproportionately affected by dementia,

Updated on:July 04,2024

Study finds no uniform brain shrinkage pattern in Alzheimer's

byUniversity College LondonMapped is the proportion of participants with a high rate of atrophy in cortical (left) and subcortical (right) areas. AD, Alzheimer's disease; MCI, mild cognitive

Updated on: October 16,2024

Study finds no uniform brain shrinkage pattern in Alzheimer's

byUniversity College LondonMapped is the proportion of participants with a high rate of atrophy in cortical (left) and subcortical (right) areas. AD, Alzheimer's disease; MCI, mild cognitive

Updated on:October 16,2024

Using tau imaging as diagnostic marker for Alzheimer disease

by The JAMA Network JournalsThe accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tra

Updated on: March 07,2024

Using tau imaging as diagnostic marker for Alzheimer disease

by The JAMA Network JournalsThe accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tra

Updated on:March 07,2024

Research highlights misdiagnosis for people with Alzheimer's disease

by Alzheimer's Research UKResearch presented today (Tuesday 26 July) at the Alzheimer's Association International Conference 2016 suggests that men with Alzheimer's may be more likely

Updated on: March 07,2024

Research highlights misdiagnosis for people with Alzheimer's disease

by Alzheimer's Research UKResearch presented today (Tuesday 26 July) at the Alzheimer's Association International Conference 2016 suggests that men with Alzheimer's may be more likely

Updated on:March 07,2024

Children found to use the same brain network as adults for tough problems

by The Ohio State UniversityCredit: Pixabay/CC0 Public DomainChildren as young as 4 years old show evidence of a network in the brain found in adults that tackles difficult cognitive problems, a

Updated on: May 13,2024

Children found to use the same brain network as adults for tough problems

by The Ohio State UniversityCredit: Pixabay/CC0 Public DomainChildren as young as 4 years old show evidence of a network in the brain found in adults that tackles difficult cognitive problems, a

Updated on:May 13,2024

New therapy may rapidly reverse life-changing sepsis-induced brain injury, animal study suggests

by Florey Institute of Neuroscience and Mental HealthCredit: Florey Institute of Neuroscience and Mental HealthFlorey researchers have shown that an extremely large "megadose" of sodium asco

Updated on: July 05,2024

New therapy may rapidly reverse life-changing sepsis-induced brain injury, animal study suggests

by Florey Institute of Neuroscience and Mental HealthCredit: Florey Institute of Neuroscience and Mental HealthFlorey researchers have shown that an extremely large "megadose" of sodium asco

Updated on:July 05,2024

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o

Updated on: April 10,2024

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o

Updated on:April 10,2024

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused

Updated on: April 16,2024

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused

Updated on:April 16,2024

Benzodiazepines increase mortality in persons with Alzheimer's disease

by University of Eastern FinlandBenzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from

Updated on: March 07,2024

Benzodiazepines increase mortality in persons with Alzheimer's disease

by University of Eastern FinlandBenzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from

Updated on:March 07,2024

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a

Updated on: March 07,2024

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a

Updated on:March 07,2024